Mechanisms for therapeutic effect of bulleyaconitine A on chronic pain-Reference-Cited by-同舟云学术

Mechanisms for therapeutic effect of bulleyaconitine A on chronic pain

Published:2018-01 Issue: Volume:14 Page:174480691879724
ISSN:1744-8069
Container-title:Molecular Pain
language:en
Short-container-title:Mol Pain

Author:

Xie Man-Xiu¹,Zhu He-Quan²,Pang Rui-Ping²,Wen Bing-Ting²,Liu Xian-Guo²³

Affiliation:

1. Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

2. Pain Research Center, Sun Yat-sen University, Guangzhou, China

3. Guangdong Provincial Key Laboratory of Brain Function and Disease, Guangzhou, China

Funder

The National Natural Science Foundation of China

Publisher

SAGE Publications

Subject

Anesthesiology and Pain Medicine,Cellular and Molecular Neuroscience,Molecular Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1744806918797243

Reference47 articles.

1. The Prevalence and Impact of Chronic Pain with Neuropathic Pain Symptoms in the General Population

2. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment

3. Do we need a third mechanistic descriptor for chronic pain states?

4. Can we conquer pain?

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Potentials of Aconite-like Alkaloids: Bioinformatics and Experimental Approaches;Mini-Reviews in Medicinal Chemistry;2024-12

2. Long-acting bulleyaconitine A microspheres via intra-articular delivery for multidimensional therapy of rheumatoid arthritis;International Journal of Pharmaceutics;2024-08

3. Current advances in the pain treatment and mechanisms of Traditional Chinese Medicine;Phytotherapy Research;2024-06-21

4. Deciphering the mysteries of Aconitum pendulum: Unique identification of various processed products and characteristic chemical markers;Arabian Journal of Chemistry;2024-02

5. A novel tRNA-derived fragment tRF-3023b suppresses inflammation in RAW264.7 cells by targeting Cul4a through NF-κB signaling;Functional & Integrative Genomics;2024-01-15